Real-World Evidence and Data Analytics Conference (Frankfurt, Germany - October 5-6, 2023): Paving the Path for Next-Gen Medicinal Research
Saturday, October 7, 2023
DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The "Real-World Evidence and Data Analytics Conference" set to take place on October 5th and 6th, 2023, in Frankfurt, Germany has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Building on five triumphant installments held in Boston, USA, this year's European chapter promises an invigorating assembly of experts, leaders, and stakeholders. The confluence aims to shed light on the accelerating evolution of real-world evidence (RWE) and its vital impact on drug benefit elucidation.
RWE, hinging on real-world data analysis, is transforming healthcare by expediting regulatory decision-making processes. Its pivotal role in patient monitoring through digital platforms, coupled with aiding clinical data organization for regulatory inclusions, is noteworthy. However, to fully harness its potential, industry leaders emphasize the importance of comprehensive guidelines and shared annotations.
Conference Highlights:
-- Delving into regulatory parameters concerning data quality & standards
-- Exploiting RWE for superior market accessibility
-- Embracing the nexus between AI, ML, and clinical trials
-- Broadening RWE's role in the digital health domain
-- Advanced analytical approaches to real-world data
-- Employing RWE to inform decisions in rare diseases
Who Should Participate?:
Professionals from pharmaceutical and biopharmaceutical sectors, specifically those vested in RWE, data analytics, HEOR, market access, clinical development, epidemiology, oncology-RWE, pharmacovigilance, life science analytics, big data, data science, and more.
Speakers Spotlight:
-- Helene Vioix, Director Global Evidence & Value Development Oncology,
Merck KGaA
-- Antje Hottgenroth, Associate Director, Real World Data
Europe/International Value, Evidence, and Outcomes (VEO) - Center of
Innovation, Lilly Deutschland GmbH
-- Ahmed H. Seddik, Senior Manager, Global HEOR & RWE, Oncology, Daiichi
Sankyo Europe GmbH
Beyond keynotes and panel discussions, attendees will benefit from extensive networking opportunities and direct interactions with esteemed speakers from leading pharmaceutical firms, global regulatory bodies, and innovative solution providers.
Agenda:
Day 1 Thu, 05-Oct-2023
-- Keynote- Real World Data - To Drive Integrated Evidence Generation
-- Maximizing the influence of RWD in cases of Rare Diseases
-- Role of Data Quality in advancing the use of RWE for Regulatory Decision
Making
-- Application of RWD/RWE in Strategy Framework and Regulatory
Considerations
-- Solution Providers Presentation
-- Panel Discussion - Creating Value from Next Generation RWE
-- Research and Related Initiatives to Evaluate and Improve RWD for
Evidence Generation
-- RWD in Drug Development Program
-- Evening Refreshments and Poster Presentation - One-to-One Networking
-- Current Trends in Patient-Centric Clinical Research amid the Rapidly
evolving Landscape
-- Patient Engagement Strategy and Execution
-- Achieving Patient Diversity using RWE in Clinical Trials
Day 2 Fri, 06-Oct-2023
-- RWE- Trends in Global Market and Network Access
-- Patient Access to Precision Medicine Oncology
-- Obtain Insight into HEOR Complexities, Parameters and Opportunities
-- Global Landscape around Real- World Evidence
-- Panel Discussion - Patient Engagement Strategy and Execution
-- Pricing Market Access Strategies Case Studies
-- Assessing Patient centered approach to value-based approach
Secure Your Seat: To further explore the conference details, please visit https://www.researchandmarkets.com/r/1nycam
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/real-world-evidence-and-data-analytics-conference-frankfurt-germany---october-5-6-2023-paving-the-path-for-next-gen-medicinal-research-301943196.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
|
